Larrauri A - Search Results

1

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.

Kissling E, Hooiveld M, Martínez-Baz I, Mazagatos C, William N, Vilcu AM, Kooijman MN, Ilić M, Domegan L, Machado A, de Lusignan S, Lazar M, Meijer A, Brytting M, Casado I, Larrauri A, Murray JK, Behillil S, de Gier B, Mlinarić I, O'Donnell J, Rodrigues AP, Tsang R, Timnea O, de Lange M, Riess M, Castilla J, Pozo F, Hamilton M, Falchi A, Knol MJ, Kurečić Filipović S, Dunford L, Guiomar R, Cogdale J, Cherciu C, Jansen T, Enkirch T, Basile L, Connell J, Gomez V, Sandonis Martín V, Bacci S, Rose AM, Pastore Celentano L, Valenciano M; I-MOVE-COVID-19 and ECDC primary care study teams; I-MOVE-COVID-19 and ECDC primary care study team (in addition to authors above). Kissling E, et al. Among authors: larrauri a. Euro Surveill. 2022 May;27(21):2101104. doi: 10.2807/1560-7917.ES.2022.27.21.2101104. Euro Surveill. 2022. PMID: 35620997 Free PMC article.

2

The biotransformation of the ergot derivative CQA 206-291 in human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance.

Vickers AE, Connors S, Zollinger M, Biggi WA, Larrauri A, Vogelaar JP, Brendel K. Vickers AE, et al. Among authors: larrauri a. Drug Metab Dispos. 1993 May-Jun;21(3):454-9. Drug Metab Dispos. 1993. PMID: 8100501

3

Biotransformation of a somatostatin analogue in precision-cut liver and kidney slices from rat, dog and man.

Connors MS, Larrauri A, Dannecker R, Nufer R, Brendel K, Vickers AE. Connors MS, et al. Among authors: larrauri a. Xenobiotica. 1996 Feb;26(2):133-41. doi: 10.3109/00498259609046695. Xenobiotica. 1996. PMID: 8867998

4

Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision.

Cano R, Larrauri A, Mateo S, Alcalá B, Salcedo C, Vázquez JA. Cano R, et al. Among authors: larrauri a. Euro Surveill. 2004 Jul;9(7):11-5. Euro Surveill. 2004. PMID: 15318008

5

Increased influenza activity in Spain from mid-December 2004.

de Mateo S, Larrauri A, Martín C; Grupo de Vigilancia de la Gripe en España. de Mateo S, et al. Among authors: larrauri a. Euro Surveill. 2005 Jan 20;10(1):E050120.2. doi: 10.2807/esw.10.03.02620-en. Euro Surveill. 2005. PMID: 16556946 No abstract available.

6

Characterisation of swabbing for virological analysis in the Spanish Influenza Sentinel Surveillance System during four influenza seasons in the period 2002-2006.

Larrauri A, de Mateo S; Spanish Influenza Sentinel Surveillance System. Larrauri A, et al. Euro Surveill. 2007 May 1;12(5):E5-6. doi: 10.2807/esm.12.05.00706-en. Euro Surveill. 2007. PMID: 17991396

7

First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States.

Valenciano M, Ciancio B, Moren A; Influenza Vaccine Effectiveness Working Group. Valenciano M, et al. Euro Surveill. 2008 Oct 23;13(43):19015. doi: 10.2807/ese.13.43.19015-en. Euro Surveill. 2008. PMID: 18947520 Free article.

8

Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries.

ECDC working group on influenza A(H1N1)v. ECDC working group on influenza A(H1N1)v. Euro Surveill. 2009 Jun 11;14(23):19238. doi: 10.2807/ese.14.23.19238-en. Euro Surveill. 2009. PMID: 19531343 Free article.

9

"I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9.

Kissling E, Valenciano M, Falcao J, Larrauri A, Widgren K, Pitigoi D, Oroszi B, Nunes B, Savulescu C, Mazick A, Lupulescu E, Ciancio B, Moren A. Kissling E, et al. Among authors: larrauri a. Euro Surveill. 2009 Nov 5;14(44):19388. Euro Surveill. 2009. PMID: 19941774 Free article.

10

Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain.

Savulescu C, Valenciano M, de Mateo S, Larrauri A; cycEVA Study Team. Savulescu C, et al. Among authors: larrauri a. Vaccine. 2010 Apr 1;28(16):2903-7. doi: 10.1016/j.vaccine.2010.01.054. Epub 2010 Feb 11. Vaccine. 2010. PMID: 20153351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page